Tracey A. Parnell, MD, MRM.

Presented by Tracey A. Parnell, MD. 

 

Polycystic ovary syndrome (PCOS) is a common yet underdiagnosed endocrinopathy estimated to affect between  8-13% of women of reproductive age, with some estimates as high as 20% depending on the diagnostic criteria used [1], [2], [3]. Many women may not recognize that they have the condition, are misdiagnosed, and don't receive appropriate evaluation and treatment.

Fertility teachers and practitioners play a crucial role in the early identification and recognition of PCOS, as well as provide consistent and regular support in diet, lifestyle, and behavioral modifications.

Key Learning Outcomes: 

  1. Understand screening tools used for PCOS diagnosis
  2. List some research-based supplement suggestions for PCOS management
  3. Understand the basic underlying pathophysiology of PCOS
  4. Generate awareness of the complexity of PCOS hormonal interaction

 

 

Dr Tracey Parnell is a Canadian physician and researcher with a passion for reproductive medicine that empowers patients and providers. She is the Research Evaluation and Quality Improvement Sector Lead for the Rural Coordination Centre of BC, which works on behalf of the Joint Standing Committee, an entity that advises the BC government and the BC Medical Association.

She is also an Assistant Clinical Professor at the University of British Columbia and the Director of Communications and Development for the International Institute for Restorative Reproductive Medicine, an organization uniting providers who share a common belief that patients deserve scientifically-based and well-researched reproductive healthcare services that cooperate with and restore reproductive function.

 

Tracey Parnell, MD.

Tracey Parnell, MD.

Assistant Clinical Professor, UBC. IIRRM Board of Directors.

 

  1. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study. J Clin Endocrinol Metab 1998;83:3078–3082
  2. Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: A systematic review and meta-analysis. Hum Reprod 2016;31:2841–2855
  3. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010 Feb;25(2):544-51. doi: 10.1093/humrep/dep399. Epub 2009 Nov 12. PMID: 19910321.
  4. Kim CH, Lee SH. Effectiveness of Lifestyle Modification in Polycystic Ovary Syndrome Patients with Obesity: A Systematic Review and Meta-Analysis. Life (Basel). 2022 Feb 18;12(2):308. doi: 10.3390/life12020308. PMID: 35207595; PMCID: PMC8876590.
  5. Lim SS, Hutchison SK, Van Ryswyk E, Norman RJ, Teede HJ, Moran LJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2019 Mar 28;3(3):CD007506. doi: 10.1002/14651858.CD007506.pub4. PMID: 30921477; PMCID: PMC6438659.

 

Events from this speaker/host

Today